Device for removing needle shield
By designing connectors that are adapted to different shapes and types, the difficulty of removing needle shields in the injection device is solved, and the stable connection and simple assembly of needle shields are achieved, which improves the efficiency of the device.
Patent Information
- Application Number
- CN202080041497.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2019-06-04
- Filing Date
- 2020-06-03
- Publication Date
- 2024-11-05
- Estimated Expiration
- 2040-06-03
Smart Images

Figure CN113950344B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to an apparatus, in particular an apparatus for removing a needle shield, and a method for manufacturing the apparatus and a drug delivery device. Background Art
[0002] Injection devices (such as automatic syringes) are known in the art for dispensing a medicament to an injection site of a patient. Such injection devices typically include a housing and a cap that is usually releasably connected to the housing. A syringe, usually including a needle, is sometimes located in the housing of the injection device (regularly prefilled with a drug, i.e., a so-called prefilled syringe), wherein its needle is sometimes covered by a removable needle shield. The needle shield can shield the interior of the syringe from the environment, for example to maintain the long-term sterility of the contents of the reservoir. When attached to the housing, the cap can cover the distal end of the housing. When the cap is removed, the syringe can be visible upon close inspection of the uncovered opening in the housing. In order to prepare the device for a delivery operation, it may be necessary to remove the cap and the needle shield.
[0003] There are different types of needle shields, for example, so-called rigid needle shields (RNS for short) and soft needle shields (SNS). Both types can be soft inside, while the types can differ in the outer surface or shell, which is rigid for RNS and soft for SNS. RNS can have a multi-part construction (e.g., a rigid part that receives a soft part in its interior), and SNS can consist of a single part, for example of an elastomeric material.
[0004] In order to prepare the device for delivering a dose, the protective needle shield must be removed from the needle. This can be done by grasping or grabbing the protective needle shield and pulling it away from the needle.
[0005] There remains a need for improvements related to needle shield removal. Summary of the invention
[0006] The object of the present invention is to provide an improved mechanism for removing a needle shield. This object is achieved by the subject matter according to the independent claims, wherein the dependent claims and the remaining disclosure may provide advantageous embodiments and improvements.
[0007] According to the present invention, there is provided a device comprising
[0008] a needle unit comprising a needle arranged along a first axis,
[0009] - a needle shield covering the needle;
[0010] - main part;
[0011] - a connector for connecting the needle shield to the main part by a forced connection or an adhesive bond, such that the needle shield is removed when the main part is moved away from the needle along the first axis.
[0012] An advantage of the present invention and all its variations is that the assembly is simple and the connector can be applied to needle shields of different geometries and / or types. For example, the connector can be adapted to different needle shields having different outer profiles when viewed towards the needle of the syringe. A specific connector for a forced fit or a form fit or for an adhesive connection can be advantageously applied to various needle shields of different shapes or types. The same type of needle shield (e.g., RNS or SNS) can be obtained in various geometries (e.g., including different regular and / or irregular outer profiles). For example, the diameter can vary angularly and / or axially between different needle shields, for example, relative to the first axis along which the needle is oriented. The specific geometry of the RNS can vary from manufacturer to manufacturer, even for syringes with nominally the same liquid volume inside them. The connector can be designed to compensate for differences between needle shields that are different in type or geometry. The needle can have an open end. The open end of the needle can form a needle outlet. The needle inlet (away from the open end) can be arranged to be fluidically connected to a liquid reservoir, or can be fluidically connected to a liquid reservoir. During operation of the drug delivery device, liquid may enter the needle through the inlet and exit the needle through the open end or outlet.For example, the reservoir may be a pre-filled syringe or cartridge.
[0013] In an exemplary embodiment, the device includes an attachment portion, wherein the attachment portion is mechanically connected to the main part, or wherein the attachment portion is integrated into the main part. The attachment portion and the main part can establish or can form an integral body structure. The attachment portion can provide an additional option for connecting another part (e.g., a connector) to the main part, which is advantageous. Embodiments of these parts are described in other embodiments. The attachment portion can deviate from the open end of the needle and be axially offset from the needle.
[0014] In another exemplary embodiment, the device includes a cap. The cap may include a main portion. The main portion may provide an outer surface of the cap and / or define an inner space of the cap.
[0015] Thus, the needle shield may be arranged in the inner space and the cap may be connected to the needle shield such that the needle shield is removed together with the cap, for example when the cap is detached from a housing of a device to which it is releasably attached.
[0016] In an embodiment, the cap comprises a closure portion covering an opening of the main part away from the needle or axially offset from the needle in a direction away from the needle opening. The closure portion may preferably be permanently and / or non-releasably connected to the main part (e.g., by a snap fit).
[0017] A multi-part cap with separate parts assembled together (e.g. a main part and at least another part like a closing part) enables the connection piece to be connected to the needle shield and / or to the main part or another part of the cap after the main part is positioned in the desired position relative to the needle shield (wherein the needle shield should be connected to the main part and preferably to the connection piece before the closing part is connected to the cap). The connection piece for forced connection or adhesive bonding can be arranged in the main part and / or can be retained therein, as a separate component or integrated into another part of the cap.
[0018] In an embodiment, at least one section of the connector or only one section of the connector is accessible through the opening, in particular when the closure part is not connected to the main part or is removed from the main part when it is connected.
[0019] In an embodiment, the connector may be inaccessible when the closure portion is connected to the main portion. Thus, once the closure portion has been assembled to the main portion, the connector may be shielded and no longer accessible for operation as the closure portion prevents access to the connector. Thus, the closure portion prevents tampering with the connector.
[0020] In a further exemplary embodiment, the connector comprises at least one arm, preferably a plurality of arms. The (corresponding) arm may be movable. The (corresponding) arm may be, for example, elastically and / or plastically deflectable and / or, for example, elastically and / or plastically deformable. The (corresponding) arm may extend along an outer surface of the needle shield. The outer surface may be a side surface, which extends along the needle and / or starts from an end surface of the needle shield covering the open end of the needle. The (corresponding) arm may be oriented along a first axis (e.g., parallel to the axis). The plurality of arms may define a holding space between the arms, in which the needle shield is arranged. The (corresponding) arm may comprise at least one tine or barb. The tine or barb may be arranged close to or form a free end of the (corresponding) arm. The tine or barb may, for example, extend radially inwardly from the (corresponding) arm and / or towards the needle shield, preferably so as to establish a forced connection between the at least one tine or barb and the needle shield. The corresponding arm may pivot about or relative to a pivot. The pivot may be provided by and / or arranged in the main part.The pivot may be axially offset from the open end of the needle, preferably away from the open end of the needle and away from the needle, preferably away from the needle entrance.
[0021] By means of the arm, a connection feature (e.g., a tine or barb) on the arm can be positioned at a desired position relative to the needle shield. As seen along the needle shield, the connection feature can be axially arranged at a position between the end of the needle shield and the open end of the needle.
[0022] In a further exemplary embodiment, the apparatus comprises a base portion. The base portion may extend obliquely to (eg, perpendicular to) the first axis. At least one movable arm may be connected to the base portion.
[0023] The base part can be used to establish a connection between the connector and another part (e.g., a part of the cap, such as the main part or the closing part). Thus, the connector can be reliably fastened relative to the main part and / or the closing part via the base part. The base part can be fastened axially and / or rotationally relative to the main part.
[0024] In an embodiment, the (corresponding) arm is radially supported to resist radially outward displacement and / or is restricted with respect to radially outward movement, for example by a support feature. The support feature may be arranged in the main part. The support feature may prevent the connection feature from disengaging from the needle shield, in particular when the radially outward movement is in a direction away from the needle shield. The support feature may abut the arm or be arranged to abut the arm before the connection feature can disengage from the needle shield. The support feature may be connected to a part of the cap (e.g., the main part or the closing part), for example, formed integrally therewith. Alternatively, the support feature may be a separate part, for example, a part movably retained in a housing to which the cap is connected. The support feature may be part of a needle cover. The needle cover may be arranged to cover the needle, in particular after the cap has been removed and / or after a dispensing or injection operation has been performed using the device.
[0025] In a further exemplary embodiment, at least one movable arm originates from a base portion (e.g., originates from a radial end region of the base portion) and extends along a first axis, wherein at least one movable arm has a section extending radially inwardly parallel to the first axis or toward the first axis in an end region away from the base portion. The section extending inwardly can be a connecting feature of the arm, such as a tine or a barb. The section extending inwardly can extend obliquely to or perpendicularly to the first axis. The section extending inwardly can be oriented or pointed backward (e.g., toward the base portion) and / or extend along another section of the movable arm, the other section preferably being offset radially outwardly from the section extending inwardly.
[0026] In this way a reliably operating connection may be provided.Manufacturing of the connection (eg by stamping and bending) may be facilitated if the arms extend from the radial end regions.
[0027] In a further exemplary embodiment, at least one movable arm is preferably directed toward the needle shield to penetrate or pass through the attachment portion of the main portion. In other words, the base portion can be arranged on one side of the attachment portion (e.g., the side facing away from the needle and / or the needle shield), and one or more arms can extend toward the needle shield, for example, through an opening defined by the attachment portion and / or laterally adjacent to the attachment portion. One or more arms can extend to the side of the attachment portion facing the needle or the needle shield. The base portion can be fastened (e.g., forcibly connected and / or rotationally fastened) to the attachment portion. At least one movable arm can be forcibly connected to the needle shield via a fork or a barb. The movable arm and the base portion can be formed by a clamp.
[0028] In this embodiment, assembling the device is quite simple because it only requires a connector (e.g., a clamp) to force the cap to connect to the needle shield. Once the cap is removed, the needle shield will also be removed. In addition, the required parts, such as the cap, a separate connector (e.g., a clamp) and the needle shield can be manufactured separately. For example, by using different clamp sizes, the device for removing the needle shield can easily cope with different sizes and geometries of the needle shield. There is no need to adjust the geometry of the main part, the attachment part and / or the closing part. The connector can be guided axially so that one or more arms travel along the outer surface of the needle shield without contacting the needle shield during the axial travel. Once the axial end position (e.g., the position where the base part abuts the attachment part) has been reached, the arm can be displaced inwardly. During this displacement process, the arm can be plastically deformed. The connection feature on the arm can penetrate the needle shield (e.g., through the rigid shell) and establish a forced connection. Therefore, the connector (e.g., the clamp) can be located in the correct position without an axial insertion force acting on the needle shield. Only the tines or barbs need to be pushed radially inwards, for example by an assembly tool, resulting in plastic deformation of the clip pins. This establishes a mechanical connection with the needle shield, which enables the needle shield to be removed when the cap is removed. This embodiment does not require an axial insertion force and has a reduced likelihood of disturbing the container closure integrity (CCI) (i.e., the tightness of the closure of a container (such as a syringe) closed by the needle shield).
[0029] In another exemplary embodiment, the base portion is formed as a base plate or substrate. The plate may have a connection feature for establishing a connection with the cap. The base plate may have a puncture. The puncture may be a connection feature for establishing a connection with the attachment portion. The puncture may be arranged at the first axis. The puncture may be provided for forcibly connecting the base plate to the attachment portion of the cap, or the base plate may be forcibly connected to the attachment portion of the cap. At least one movable arm connected to the base plate (e.g., integrally formed with the base plate) may extend along the first axis and / or away from the base plate (such as toward the needle). At least one movable arm may point away from the first axis and include a barb bent toward the needle shield at its end. The barb may be oriented toward the base plate and / or extend along another section of the arm and / or between the arm and the needle shield. A plurality of arms may be circumferentially arranged and preferably evenly distributed around the base plate. One or more arms may be elastically and / or plastically displaced relative to the base plate.
[0030] Moreover, in this embodiment, only a few parts are required and the assembly is relatively simple. Compared with the previous embodiment in which a plastically deformable clamping nail can be used, in this embodiment, an elastically and / or plastically deformable arm can be used. The arm can point away from the first axis. When the needle shield contacts the barb, due to their oblique orientation relative to the axis, the opening defined by the barb can be widened while the arm is elastically displaced. The elastic restoring force can maintain contact between the barb and the needle shield. Alternatively, the opening defined by the arm can be configured to receive the needle shield without deforming or displacing the arm. In this case, the size of the opening can be determined to receive the needle shield, for example, there can be a circumferential gap between the needle shield and the barb.
[0031] The connector of this embodiment is also able to cope with different needle shield geometries or sizes, because the elastically and / or plastically deformable arms are simply bent radially further outward or inward to adapt to the shape and size of the needle shield. Once the base plate is fixed to the attachment part, the arm and / or the needle shield and the barb have been properly positioned relative to each other, and the barb can be pushed towards the needle shield. The push can be achieved by the closing part, in particular by the movement of the closing part attached to the main part. For example, the support feature can force the arm inward against the needle shield to establish or strengthen the forced connection with the needle shield. The support feature can also support the arm radially outward to resist radial outward displacement. The support feature can be arranged inside the main part. This support feature can include a needle cover, which is arranged along the first axis and is movable relative to the main part and / or relative to the needle along the first axis. The support feature can also include a cover wedge or a cover clamp. This embodiment does not require insertion force (especially if the arms do not have to deform when they are guided along the needle shield) and has a reduced possibility of interfering with the CCI.
[0032] In another exemplary embodiment, the closing portion or the main portion interacts with the support feature so that the arm bends radially inward toward the needle shield. In this way, a mechanically forced connection between the needle shield and the barb is established only when the closing portion closes the main portion, which results in a force directed radially inward from the support feature toward the arm and the barb. For this embodiment, no separate assembly tool is required to force the barb to form a forced connection with the needle shield. Moreover, in this embodiment, assembly is simple and the main portion, connector and needle shield can be manufactured separately. This embodiment does not necessarily require an insertion force (i.e., a force acting on the needle shield during the process of inserting the needle shield into the connector space laterally defined by the connector (e.g., arm)) and has a reduced likelihood of interfering with the CCI.
[0033] In a further exemplary embodiment, the connecting piece comprises two movable arms arranged opposite each other, wherein the needle shield is arranged between the arms.
[0034] In a further exemplary embodiment, the connector comprises an annular disc or ring which surrounds the needle shield so as to establish a positive connection between the annular disc or ring and the needle shield. In this embodiment, the connector may be axially constrained to the needle shield, i.e. it does not extend axially beyond the needle shield. This embodiment may have the advantage that the connection or mechanical interaction between the connector and the main part is achieved laterally with respect to the needle shield, which may improve or facilitate the transmission of forces to the needle shield.
[0035] In another exemplary embodiment, the annular disk or ring is embedded in the main part so that they cannot be separated non-destructively. This embedding can be achieved by a molding process as described below. The annular disk or ring includes a barb pointing toward the needle shield, thereby establishing a mechanical connection between the barb and the needle shield. In this embodiment, no additional assembly tool is needed to establish a forced connection between the barb and the needle shield. When the main part with the barb covers the needle shield, a forced connection is established. The annular disk or ring and the barb can include metal, and the main part can include plastic molded around the annular disk or ring. Therefore, the use of metal barbs provides a stable and reliable connection between the barb and the needle shield. The use of plastic for the main part results in a lighter and less expensive device overall.
[0036] In a further exemplary embodiment, the ring comprises a circlip with a gap, the gap allowing the circlip to be elastically deformed so that the enclosed area can be increased or decreased, wherein the circlip has a smaller inner diameter than the needle shield, so that the circlip applies a force to the needle shield when it surrounds the needle shield so as to establish a positive connection between the circlip and the needle shield. The circlip also has a positive connection to the main part. This embodiment provides a simple connector, which can be adapted to different sizes of needle shields due to its elastically deformable shape. Moreover, it requires an assembly tool to adjust the circlip in the correct position, but no insertion force is required.
[0037] In a further exemplary embodiment, the adhesive bond is formed by a UV curable adhesive. The embodiment requires even fewer mechanical parts and can also cope with different geometries of the needle shield. No insertion force is required to establish the adhesive connection between the main part and the needle shield. This embodiment does not require an insertion force and has a reduced likelihood of interfering with the CCI.
[0038] In another aspect of the present invention, there is provided a method for manufacturing a device, the method comprising the steps of:
[0039] - providing a needle unit comprising a needle defining a first axis;
[0040] - Provide needle shield;
[0041] - Provide the main part;
[0042] - forming a connection for positively connecting the needle shield to the main part so that the needle shield can be removed when the main part or the cap with the main part is moved away from the needle along the first axis.
[0043] In an exemplary embodiment of the method, the connecting element comprises a ring which is co-molded directly into the main part for establishing a positive connection.
[0044] In further exemplary embodiments of the method, the connector comprises an adhesive for establishing an adhesive bond of the needle shield to the main portion such that the needle shield is removed when the main portion is moved away from the needle along the first axis.
[0045] In another aspect of the invention, a drug delivery device (eg an autoinjector) comprising a device according to the invention is provided. The drug delivery device comprises a housing, wherein the housing comprises a cap having a closing portion, and wherein the housing covers the device according to the invention. BRIEF DESCRIPTION OF THE DRAWINGS
[0046] Embodiments will now be described, by way of example only, with reference to the accompanying drawings, in which:
[0047] FIG1A is a schematic cross-sectional view of a first embodiment of the present invention showing a clip connected to a cap and a needle shield;
[0048] FIG1B is a schematic 3D diagram showing a portion of an attachment portion and a clip;
[0049] FIG1C is a schematic 3D diagram of a clamp;
[0050] FIG1D is a schematic cross-sectional view of a needle shield from one side;
[0051] FIG. 1E is a schematic cross-sectional view of the needle shield according to FIG. 1D but rotated 90 degrees about the first axis;
[0052] FIG1F is a schematic cross-sectional view of an alternative shaped needle shield;
[0053] FIG. 1G is a schematic cross-sectional view of the needle shield according to FIG. 1D with an assembly tool;
[0054] 1H is a schematic cross-sectional view of the needle shield shown in FIG. 1G with a different needle cover position.
[0055] FIG. 1I is a schematic 3D diagram of a top view of the main parts with the clip installed;
[0056] Fig. 2A is a schematic cross-sectional view of a second embodiment of the present invention showing a portion of a cap, a needle shield and a connector;
[0057] Fig. 2B is a schematic cross-sectional view similar to Fig. 2A but with the cap and connector moved toward the needle;
[0058] FIG2C is a schematic 3D diagram of a connector;
[0059] FIG2D is a schematic 3D diagram of a lid of a cap;
[0060] FIG2E is a schematic 3D diagram of a portion of the main parts and connectors;
[0061] FIG2F is a schematic 3D diagram showing the attachment portion of the connector connected to the main portion from a side view;
[0062] 2G to 2J are schematic cross-sectional views of the main parts and the connector attached to the cap clamp and the assembly of the cap cover to provide radial force to the connector;
[0063] FIG2K is a schematic cross-sectional view of a main portion having support features;
[0064] FIG2I is a schematic 3D diagram of a cross section of a main part;
[0065] FIG3A is a schematic 3D illustration of a third embodiment of the present invention showing an annular disk with tabs and barbs;
[0066] FIG3B is a schematic 3D illustration of a modified third embodiment showing a loop with arms and barbs;
[0067] FIG3C is a schematic 3D illustration of a modified third embodiment showing a ring with notches and barbs;
[0068] Fig. 3D is a schematic cross-sectional view of the main parts, the ring with barbs, and the insert, as seen from a side view;
[0069] Fig. 3E is a schematic cross-sectional view of a portion of an enlarged portion similar to Fig. 3D. Instead of the notches here, the flexible arms of the ring are molded into the side walls of the main portion;
[0070] FIG3F is a schematic cross-sectional view of a portion of a main portion having a ring;
[0071] FIG3G is a schematic cross-sectional view of a portion of a needle shield;
[0072] 3H is a schematic cross-sectional illustration of a portion of the needle shield in cross-sectional view from a first side, illustrating the interaction of the barbs with the needle shield;
[0073] FIG3I is a schematic cross-sectional view of a portion of the needle shield of FIG3H in a cross-sectional view from a second side, illustrating the interaction of the barbs with the needle shield;
[0074] FIG3J is a partial cross-sectional view of a needle shield different from the needle shields of FIGS. 3H and 3I , illustrating the interaction of the barbs with the needle shield;
[0075] FIG4A is a schematic 3D illustration of a fourth embodiment of the present invention showing a circlip;
[0076] 4B to 4D are schematic cross-sectional views of the assembly process when the circlip is attached to the main part;
[0077] 5A is a schematic cross-sectional view of a fifth embodiment of the present invention showing a needle shield adhesively connected to a main portion;
[0078] FIG5B is a schematic cross-sectional view of plasma treatment of a needle shield;
[0079] 5C-5E are schematic cross-sectional views of a drug delivery device and the steps of applying an adhesive for connecting the needle shield to the main portion. DETAILED DESCRIPTION
[0080] The same reference numerals are applied to the same features.
[0081] FIG1A is a schematic cross-sectional view of a first embodiment of the present invention. It shows a cap 121, a needle shield 103, a needle 101, and a portion of a connector 113, 213, 313, 315, 413, 513 including a clamp 113. The needle 101 is arranged along a first axis Y and is surrounded by the needle shield 103. The cap 121 includes a main portion 127 covering the needle shield 103, and further includes an attachment portion 109 arranged across the main portion 127. The main portion 127 may also be referred to as a cap tube 127.
[0082] The clamp 113 comprises a base portion 107 extending perpendicularly to the first axis Y. It comprises an arm 111 extending away from the base portion 107 and towards the needle 101 along the first axis Y, wherein the base portion 107 connects the arm 111. At the arm 111, a fork tine 105 is provided which extends radially inwardly towards the needle shield for establishing a forced connection.
[0083] The clamping nail 113 is arranged so that the arm 111 passes through the attachment portion 109 of the cap 121 in the direction of the needle shield 103 along the first axis Y. The attachment portion 109 is arranged between the base portion 107 and the fork tine 105 on the first axis Y, thereby connecting the clamping nail 113 with the cap 121 and the needle shield 103.
[0084] 1A further shows an assembly tool 115 for adjusting the clamping spike 113 relative to the needle shield 103. The assembly tool 115 includes a lever arm 117 for applying a radially inwardly directed force at the end of the arm 111 of the clamping spike 113 so that the tines 105 are pressed into the needle shield 103.
[0085] Further shown is a schematic coordinate system having a first axis Y and a second axis X, which are respectively arranged at right angles to the first axis Y, wherein the first axis Y and the second axis X are both arranged on the drawing level.
[0086] FIG1B is a schematic 3D diagram showing a portion of the attachment portion 109 and the clamping nail 113 of the cap 121. The base portion 107 of the clamping nail 113 is arranged across the attachment portion 109, and the arms 111 of the clamping nail 113 are elongated along the first axis, wherein the prongs 105 are radially inwardly pointed at their ends toward the needle shield 103 (not shown in this figure). The base portion 107 and the attachment portion 109 establish a forced connection, so that the base portion 107 and the subsequent clamping nail 113 are radially fastened.
[0087] FIG. 1C is a schematic 3D diagram of a clamp 113, which comprises a base plate 107, four arms 111, and a tine 105 at each end of each arm 111. The arms 111 are connected by the base plate 105, thereby forming a U-shape. The tine 105 points radially inwardly toward the needle shield 103 and the first axis Y. The arms 111 are arranged in pairs facing each other on opposite sides of the first axis Y. The arms 111 can also be arranged to have another distance between each other in the radial direction around the first axis Y, such as an equal distance, wherein the distance of the arms 111 to the first axis Y is always the same. The clamp 113 can also include two, three or more than four arms 111. Instead of the tine 103, the arm 111 can also include a barb 203 or other sharp or pointed end that can grab the needle shield 103. Compared with the tine 103, the barb 203 has a terminal with a larger angular extension, for example, with multiple points.
[0088] FIG1D is a schematic cross-sectional view of the device according to the invention rotated 180 degrees about the second axis X relative to FIG1A . It shows the main part 127 and the needle cover 119. The clamping nail 113 is connected to the needle shield 103 having a cross-sectional plane across the first axis Y, wherein the width of the needle shield 103 is greater than the depth of the needle shield 103. The depth of the needle shield extends in a direction perpendicular to the drawing plane. The cross section of the needle shield 103 is shown from the first side, and its width extends perpendicular to the first axis Y and parallel to the second axis X. The base portion 103 of the clamping nail 113 is such that the arm 111 tightly covers the width of the needle shield 103.
[0089] FIG. 1E is a schematic cross-sectional view of a portion of the main portion 127 of FIG. 1D in a cross-sectional view from the second side, which is rotated 90 degrees about the first axis Y relative to the view of FIG. 1E . The cross section of the needle shield 103 is shown from the second side, and its depth also extends parallel to the second axis X in this view. The base portion 103 of the clamping pin 113 allows some space between the arm 111 and the needle shield 103. The clamping pin 113 is connected to the needle shield 103 across the depth of the needle shield 103, which can also be referred to as a gripping plane. The arm 111 of the clamping pin 113 covers the width of the needle shield 103, wherein the remaining space between the needle shield 103 and the arm 111 of the clamping pin 113 is similar on both sides of the needle shield 103. Such a needle shield 103 is used, for example, in prefilled syringes available from Becton Dickinson.
[0090] FIG. 1F is a schematic cross-sectional view of a portion of the main portion 127 in cross-sectional view, wherein the needle shield 103 has an alternative shape compared to FIG. 1D and FIG. 1E. In this view, the maximum diameter across the needle shield 103 is shown. The needle shield 103 has a flat edge. The cross-section of this needle shield 103 according to this embodiment can be circular. Such a needle shield 103 is used for a prefilled syringe available from Ompi.
[0091] FIG1G is a schematic cross-sectional view of a similar cross-sectional view compared to FIG1D . Furthermore, a lever arm 117 of an assembly tool 115 for adjusting the clamping pin 113 at the needle shield 103 is shown in FIG1G . The lever arm 117 applies a force to the radially inwardly directed ends of the arms 111 of the clamping pin 113 so that the tines 105 are pressed into the needle shield 103. The assembly tool 115 can be moved in the direction of the first axis Y and therefore requires less radial clearance in the main portion 127.
[0092] FIG. 1H is a schematic cross-sectional view of a similar cross-sectional view compared to FIG. 1G . In FIG. 1H , the needle cover 119 is in a lower position relative to the first axis Y. Adjusting the clamp 113 can also potentially occur in the same step as the pre-filling step, where the needle cover 119 is pushed further downward (e.g., more than 3 mm, e.g., 3.13 mm), thereby increasing the radial space available for assembly tools. The pre-filling process enables the drug delivery device 501 (such as an automatic injector 501) to be used by a user. During the pre-filling process, the needle cover 119 moves in the direction of the needle 101.
[0093] Fig. 1I is a schematic 3D diagram showing, from the top, a part of the attachment portion 109 of the main part 127 and the clamping pin 113. Further, the needle cover 119 is shown.
[0094] The advantages of this embodiment and its variants are that the assembly is very simple and the parts (i.e., the needle shield 103, the main part 127 and the clip 113) can be manufactured separately. As can be seen from Figures 1D and 1E, the clip 113 can be adapted to different geometries of the needle shield 103. Finally, it does not require axial insertion forces and has a reduced likelihood of disturbing the container closure integrity (CCI). Complex structures for positioning the clip (such as positioning bosses) can be avoided.
[0095] Fig. 2A is a schematic cross-sectional view of a second embodiment of the present invention. It shows a cap 121 with an attachment portion 109 and a main portion 127, a needle shield 103, a needle 101, and a portion of a connector 213, the connector comprising a base plate 201 and an arm 205 attached to the base plate 201. The arm 205 extends away from the base plate 205 and towards the needle 101 along a first axis Y. The arm 205 points away from the first axis Y in the direction of the second axis X and then opens an angle between the arm 205 and the first axis Y. The arm 205 comprises a barb 203 at its end, which is bent towards the needle shield 103. Because the arm 205 points away from the first axis Y, the arm 205 together with the barb 203 can cover and connect the needle shield 103, which has a larger cross-section than the diameter of the base plate 201 of the connector 213. In order to have a strong connection between the barb 203 and the needle shield 103, in particular when the cap 121 moves away from the needle 101 with the connector 213, the angle between the bent barb 203 and the arm 205 is 90 degrees or less. The connector 213 and the arm 205 with the barb 203 may include plastic or metal.
[0096] Figure 2B is a schematic cross-sectional view similar to Figure 2A, but includes a closing portion 123, which includes a cover 123 of the cap 121, which moves toward the needle shield 103 in the direction of the first axis Y, thereby engaging the hook 203 and the arm 205 of the connecting member 213, so that the hook 203 is connected to the needle shield 103.
[0097] 2C is a schematic 3D diagram of a connector 213. The connector 213 includes a backplane 201 having a punch-out 207 that may be at the center of the backplane 201. The punch-out 207 may have various shapes, such as rectangular, square, circular, or any other shape for mechanically securing the backplane 201 to the attachment portion 109 of the main portion 127.
[0098] 2D is a schematic 3D illustration of a closure portion 123, which may be a cover 123 of a cap 121. When the cover 123 is attached to the main portion 127, the cover piece 125 of the cover 123 forces the barbs 203 of the connector 213 toward the needle shield 103.
[0099] Fig. 2E is a schematic 3D illustration of a section of the main part 127 with the attachment part 109 and the connector 213 below the attachment part 109. It further shows the needle cover 119.
[0100] 2F is a schematic 3D diagram of a connector 213 connected to a cap clip 129, which is part of the attachment portion 109 of the main portion 127, from a side view. The connector 213 is mechanically connected to the cap clip 129 via the breakout 207 of the base plate 201.
[0101] 2G-2J are schematic cross-sectional views of the main portion 127 and the connector 213 attached to the cap clamp 129 and the needle shield 103. In this embodiment, the connector 213 preferably comprises metal.
[0102] 2G and 2H are schematic cross-sectional views in which the connector 213 is initially assembled to the main part 127. When they are assembled, the connector 213 avoids both the needle cover 119 and the needle shield 103. Fig. 2G shows a view rotated 90 degrees about the first axis Y relative to the view of Fig. 2H.
[0103] 2I and 2J are schematic cross-sectional views in which the cover 123 of the cap 121 is assembled to the main part 127. It forces the metal barb 203 to bend inwardly toward the needle shield 103 and make contact with the needle shield 103. The barb 203 is designed to fully contact the needle shield 103 in the lower diameter section as shown in FIG. 2J, and the barb 203 will bend and have strong contact with the needle shield 103 across its larger diameter, as shown in FIG. 2I.
[0104] This embodiment and its variations have the advantage of being very simple to assemble, requiring only a few parts and requiring little or no insertion force, and having a reduced likelihood of disturbing the CCI.
[0105] FIG2K is a schematic cross-sectional view of the main part 127 of the present invention. It shows the needle 101, the needle shield 103 and the needle cover 119. The cover wedge 221 is placed along the needle shield 103 in the direction of the first axis Y, and the bevel guide is located adjacent to the cover wedge in the direction radially outward from the needle 101. Further, the assembly includes a clamp 225, which locks the cover wedge 221 in place. The bevel 223 guides the needle shield 103 into a central position relative to the first axis Y. It optionally further includes a cover clamp 227. If the cover 123 of the cap 121 is moved downward along the first axis Y, the cover wedge 221 moves radially inward toward the needle shield 103, so that a press-fit connection occurs. This basically relies on the insertion force of the cover 123 being much greater than the cap removal force of about 35N.
[0106] FIG. 21 is a schematic cross-sectional view of the main part 127. At the main part 127, elastically deformable beams 229 are radially arranged, which beams may include prongs 105 or barbs 203. These beams 229 are able to cope with various geometries of the needle shield 103. They typically include plastic and are molded in one step with the cap 121 or the main part 127, as also described in FIG. 3D to FIG. 3G. The variation of the geometry of the needle shield 103 can cover the radial difference between the needle shield 103 between the lower diameter section with a diameter of 0.5 mm and the higher diameter section. Various beam 229 geometries can also be used to adjust for different geometries and sizes of the needle shield 103. Since the increased elastic deformability of the beam 229 leads to a reduction in the stiffness of the beam and therefore to a smaller force that can be applied to the needle shield 103, a balance needs to be found between the elastic deformability and the applied force. As an example, if a removal force of 35 N is required and the coefficient of friction is 0.2, 6 clamps are required that contact the RNS with a force of 29 N per clamp. With a beam 229 of 6 mm length, 4 mm width and 2 mm depth, for the diameter of the Becton Dickinson needle shield 103, a deflection of 0.3 mm is required for this contact force, and if there is an additional deflection of 0.5 mm, it will deform plastically. An elastic solution with only plastic parts can be considered, especially if the variability of the RNS is taken into account by wedging the plastic parts.
[0107] FIG. 3A is a schematic 3D diagram of a third embodiment of the present invention, showing an annular disk 313 with holes 305. The annular disk 313 includes an inner radius and an outer radius. The holes 305 are arranged at the annular area between the inner radius and the outer radius. The annular disk 313 further includes barbs 303 and tabs 317 arranged at the inner radius of the annular disk 313. The tabs 317 are used to locate inserts 321, which are used in the process of co-molding the annular disk 313 with the main part 127, as described in FIG. 3D and FIG. 3E. The barbs 303 are used to grab the needle shield 103. The annular disk 313 includes 6 barbs 303, which are arranged at equal intervals around the inner side of the annular disk 313. The number of barbs 303 can also be less than or more than six.
[0108] FIG3B is a schematic 3D illustration of a modified third embodiment showing an annular disk 313 without holes 305 but with flexible arms 307 that include corrugations and are mounted on the outer radius of the annular disk 313. The flexible arms 307 are used in the molding process described in FIG3D. The annular disk 313 further includes barbs 303 that are disposed at the inner radius of the annular disk 313 as described in FIG3A.
[0109] 3C is a schematic 3D view of a modified third embodiment showing a ring 315 with a notch 309 and barbs 303. The ring 315 comprises a shallow body, wherein the barbs 303 are arranged in a circular manner on the inner side of the ring 315. The barbs 303 form an angle of less than 90 degrees with the inner wall of the ring 315. The ring 315 comprises six barbs 303, which are arranged equally spaced around the inner side of the ring 315. The number of barbs 303 can also be less than or more than six.
[0110] FIG3D is a schematic cross-sectional view of an arrangement for co-molding an annular disk 313 or ring 315 with a main portion 127. In order to co-mold an annular disk 313 or ring 315, which may include metal, with a main portion 127, it is first necessary to mount the annular disk 313 or ring 315 on an injection molding tool. The inner core of the molding tool includes a two-part insert 321. For this co-molding process, the annular disk 313 or ring 315 is placed into a mold (not shown) where the main portion 127 is formed around the annular disk 313 or ring 315 using, for example, plastic as the molding material using a known injection procedure. The two-part insert 321 holds the annular disk 313 or ring 315 at its defined position relative to the main portion 127 and additionally fills the empty space in the main portion 127 so that the injected fluid plastic flows around the insert 321 to form the main portion 127 and surround the annular disk 313 or ring 315. Once the plastic is hard again, the annular disc 313 or ring 315 and the main part 127 are co-molded so that they cannot be separated non-destructively. The bond between the ring 315 and the main part 127 can be additionally enhanced by using the notches 309. Other alternatives for retaining the annular disc 313 or ring 315 on the molding tool are tabs 303 or flexible arms 307, see FIGS. 3A to 3C.
[0111] In addition, a small part of the schematic diagram is enlarged and marked with a dotted square. In this enlarged part, the notch 309 of the ring 315 is shown, through which the ring 315 is molded into the side wall of the main part 127. Therefore, liquid plastic can flow into the ring 315 and the notch 309 and flow around it.
[0112] The same applies if, instead of the ring 315 , the annular disk 313 is co-molded with the cap 121 . Here, the liquid plastic flows around the annular disk 313 and flows through the holes 305 or the flexible arms 307 .
[0113] Fig. 3E is a schematic cross-sectional view of a portion similar to the enlarged portion of Fig. 3D. Instead of the notch 309, here the flexible arm 307 of the ring 315 is molded into the main portion 217. Thus, the portion of the main portion 127 to which the ring 315 is fixed comprises liquid plastic, so that the plastic can flow into and around the ring 315 and the notch 309, and the ring 315 and the main portion 127 are ultimately molded together as described in Fig. 3D.
[0114] Fig. 3F is a schematic cross-sectional view of a fragment of the main part 127 in cross-sectional view. It shows a section of a ring 315 with some barbs 303 pointing upwards away from the needle 101 relative to the first axis Y. Tabs 317 are also positioned at the same lateral position as the ring 315 for positioning the insert 321 into the mold.
[0115] 3G is a schematic cross-sectional view of a portion of the needle shield 103, indicating that the radial clearance between the ring 315 and the RNS is approximately 0.5 mm. This ensures that the position feature is clear.
[0116] 3H is a schematic cross-sectional view of a portion of the main portion 127 of the needle shield 103 in a cross-sectional view from the first side. The needle shield 103 has a cross-sectional plane passing through the first axis Y, wherein the width of the needle shield 103 is greater than the depth of the needle shield 103. The cross section of the needle shield 103 is shown from the first side, with its width extending parallel to the second axis X. It further shows the needle 101, the needle shield 103 and the barbs 303 of the annular disk 313 or ring 315, which interact with the needle shield 103.
[0117] FIG3I is a schematic cross-sectional view of a portion of the main part 127 with the needle shield 103 in a cross-sectional view from the second side, which is rotated 90 degrees about the first axis Y relative to FIG3H. It also shows the barbs 303 of the annular disk 313 or ring 315 interacting with the needle shield 103. In this figure, a section is shown of the depth of the needle shield 103. Such needle shields are used for prefilled syringes available from Becton Dickinson.
[0118] FIG3J is a schematic cross-sectional view of a portion of a needle shield 103 that is different from the needle shields shown in FIG3H and FIG3I in a cross-sectional view. In this view, the maximum diameter across the needle shield 103 is shown. It also shows the barbs 303 of the annular disk 313 or ring 315 that interact with the needle shield 103. This type of needle shield is used in pre-filled syringes available from Ompi.
[0119] The advantages of this embodiment and its variants are that the parts of the connection are very simple, the assembly of the device is also simple and it can cope with tolerances in the position of the connection 213.
[0120] FIG4A is a schematic 3D diagram of a fourth embodiment of the present invention, showing a circlip 413 having a gap 407 so that the circlip is not closed. The gap 407 allows the circlip to bend, so that the gap 407 increases and the area surrounded by the circlip 413 increases. In the same manner, the circlip 413 can bend, so that the gap 407 decreases and the area surrounded by the circlip 413 is subsequently reduced. The bending is an elastic deformation, so that the circlip will return to its original form and original gap size without applying a force to maintain the bending. The circlip 413 has an inner radius and an outer radius and a certain thickness. The circlip 413 includes a slope from the outer radius toward the inner radius indicating a tapered shape toward the inner radius.
[0121] 4B is a schematic cross-sectional view of a portion of the main part 127 in a cross-sectional view, including an assembly tool 409, also referred to as a tapering tool 409 for the circlip 413 to be mounted on the lip 405. Also shown are the needle 101, the needle shield 103 and the needle cover 119. During assembly, the circlip 407 radially protrudes beyond the assembly tool 409, which has a larger diameter than the circlip 407. In a next step, the assembly tool 409 with the circlip 407 is then pushed downwards along the first axis Y in the direction of the needle 101.
[0122] 4C is a schematic cross-sectional view of the final position of the assembly tool 409 when it is stopped at the lip 405. In this position, the circlip 413 is pushed away from the end of the assembly tool 409 by the plunger tool 411.
[0123] 4D is a schematic cross-sectional view of a portion of the main portion 127 in cross-sectional view, including the lip 405 on which the circlip 413 rests in the final installed position around the needle shield 103. The lip 405 also serves to couple the circlip 413 to the main portion 127 or the cap 101 so that the circlip 413 and the needle shield 103 are removed when the main portion 127 or the cap 101 is removed. The needle cover 119 and the needle 101 are also shown.
[0124] The advantage of this embodiment and its variants is that the assembly is very simple and the parts (i.e. the needle shield 103, the main part 127 and the circlip 413) can be manufactured separately. The circlip 413 can be adapted to different geometries of the needle shield 103. Finally, it does not require an insertion force and has a reduced probability of disturbing the CCI.
[0125] 5A is a schematic cross-sectional view of a fifth embodiment of the present invention showing the needle shield 103 adhesively connected to the main part 127 using an adhesive 513. It further shows the needle 101.
[0126] Preferably, a UV curing adhesive is used as this is advantageous when the device is refrigerated immediately after assembly. It is required that the adhesive 513 will fully cure before freezing. The main part 127 needs to be designed so that access for dispensing the adhesive is possible.
[0127] This UV curing can be applied, for example, to fairly sticky acrylics like Loctite 3926. Once the correct wavelength and light intensity are set, UV curing is very fast and can be completed in seconds. Moreover, an online check on the presence of adhesive is possible because it fluoresces when exposed to a black light.
[0128] 5B to 5E describe the steps for applying an adhesive for connecting the needle shield 103 to the main portion 127 .
[0129] Figure 5B is a schematic cross-sectional view of a plasma treated needle shield 103. It involves millisecond application of high heat to increase the surface energy. By this plasma treatment of the needle shield 103 (polypropylene), the bond strength will be greatly increased.
[0130] 5C is a schematic cross-sectional view of a portion of drug delivery device 501 in which adhesive 513 is dispensed in a ring around main portion 127 through holes at cover 123 of main portion 127 .
[0131] FIG. 5D is a schematic cross-sectional view of a schematic portion of a drug delivery device 501 with a prefilled syringe assembled into the main portion 127 .
[0132] 5E is a schematic cross-sectional view of a schematic portion of a drug delivery device 501, wherein UV light is applied within a few seconds of the allotment to fully cure the adhesive 513. The duration of UV light application depends on the depth, but is typically less than 30 seconds.
[0133] The advantage of this embodiment and its variations is that the assembly is very simple and no separate connector parts are required. The amount of adhesive applied can be adapted to accommodate different geometries of the needle shield 103. Finally, it requires no insertion force and has a reduced likelihood of disturbing the CCI.
[0134] The connector for establishing a forced or adhesive bond and all described embodiments according to the invention can be applied to RNS as well as SNS. RNS comprises a rigid outer surface but has a less rigid material (soft) on the inner side of the needle shield. SNS comprises a less rigid material (soft) throughout the shield. The force for removing the needle shield can be 20N or more, for example, 25N or more or 30N or more.
[0135] The terms "drug" or "medicament" are used synonymously herein and describe a pharmaceutical preparation comprising one or more active pharmaceutical ingredients or a pharmaceutically acceptable salt or solvate thereof and optionally a pharmaceutically acceptable carrier. In the broadest sense, an active pharmaceutical ingredient ("API") is a chemical structure that has a biological effect on humans or animals. In pharmacology, a drug or medicament is used to treat, cure, prevent, or diagnose a disease or to otherwise enhance physical or mental health. A drug or medicament may be used for a limited duration, or periodically for a chronic disease.
[0136] As described below, a drug or medicament may include at least one API or a combination thereof in various types of formulations for treating one or more diseases. Examples of APIs may include small molecules (having a molecular weight of 500 Da or less); polypeptides, peptides, and proteins (e.g., hormones, growth factors, antibodies, antibody fragments, and enzymes); carbohydrates and polysaccharides; and nucleic acids, double-stranded or single-stranded DNA (including naked and cDNA), RNA, antisense nucleic acids such as antisense DNA and RNA, small interfering RNA (siRNA), ribozymes, genes, and oligonucleotides. Nucleic acids may be incorporated into molecular delivery systems (such as vectors, plasmids, or liposomes). Mixtures of one or more drugs are also contemplated.
[0137] In a primary package or "drug container" suitable for a drug delivery device, a drug or medicament may be included. The drug container may be, for example, a cartridge, a syringe, a reservoir or other solid or flexible vessel, which is configured to provide a suitable chamber for storing (e.g., short-term or long-term storage) one or more drugs. For example, in some cases, the chamber may be designed to store the drug for at least one day (e.g., 1 day to at least 30 days). In some cases, the chamber may be designed to store the drug for about 1 month to about 2 years. Storage may occur at room temperature (e.g., about 20 ° C) or refrigerated temperature (e.g., from about -4 ° C to about 4 ° C). In some cases, the drug container may be or may include a dual-chamber cartridge, which is configured to store two or more components (e.g., API and diluent, or two different drugs) of a pharmaceutical preparation to be administered separately, one being stored in each chamber. In this case, the two chambers of the dual-chamber cartridge may be configured to allow mixing between two or more components before and / or during distribution to the human or animal body. For example, the two chambers can be configured so that they are in fluid communication with each other (e.g., through a conduit between the two chambers), and allow the user to mix the two components if necessary before dispensing. Alternatively or additionally, the two chambers can be configured to allow mixing when dispensing the components into the human or animal body.
[0138] The medicine or medicament contained in the drug delivery device described herein can be used to treat and / or prevent many different types of medical diseases. The example of disease includes, for example, diabetes or complications associated with diabetes (such as diabetic retinopathy), thromboembolic disorders (such as deep vein or pulmonary thromboembolism). Another example of disease is acute coronary syndrome (ACS), angina pectoris, myocardial infarction, cancer, macular degeneration, inflammation, hay fever, atherosclerosis and / or rheumatoid arthritis. The example of API and medicine is those as described in the following manual: such as Rote Liste 2014 (for example, but not limited to, main group (main group) 12 (antidiabetic drugs) or 86 (tumor drugs)) and Merck Index, the 15th edition.
[0139] Examples of APIs for treating and / or preventing type 1 or type 2 diabetes or complications associated with type 1 or type 2 diabetes include insulin (e.g., human insulin, or human insulin analogs or derivatives); glucagon-like peptide (GLP-1), GLP-1 analogs or GLP-1 receptor agonists, or analogs or derivatives thereof; dipeptidyl peptidase-4 (DPP4) inhibitors, or pharmaceutically acceptable salts or solvates thereof; or any mixture thereof. As used herein, the terms "analogs" and "derivatives" refer to polypeptides having a molecular structure that can be derived from the structure of a naturally occurring peptide (e.g., the structure of human insulin) in form by deleting and / or exchanging at least one amino acid residue present in a naturally occurring peptide and / or by adding at least one amino acid residue. The added and / or exchanged amino acid residues can be codable amino acid residues or other natural residues or purely synthetic amino acid residues. Insulin analogs are also referred to as "insulin receptor ligands." In particular, the term "derivative" refers to a polypeptide having a molecular structure that is formally derived from the structure of a naturally occurring peptide (e.g., the structure of human insulin), wherein one or more organic substituents (e.g., fatty acids) are bound to one or more amino acids. Alternatively, one or more amino acids present in the naturally occurring peptide may have been deleted and / or replaced by other amino acids (including non-encodable amino acids), or amino acids (including non-encodable amino acids) have been added to the naturally occurring peptide.
[0140] Examples of insulin analogs are Gly(A21), Arg(B31), Arg(B32) human insulin (insulin glargine); Lys(B3), Glu(B29) human insulin (insulin glulisine); Lys(B28), Pro(B29) human insulin (insulin lispro); Asp(B28) human insulin (insulin aspart); human insulin in which the proline at position B28 is replaced by Asp, Lys, Leu, Val or Ala and in which the Lys at position B29 may be replaced by Pro; Ala(B26) human insulin; Des(B28-B30) human insulin; Des(B27) human insulin and Des(B30) human insulin.
[0141] Examples of insulin derivatives are, for example, B29-N-myristoyl-des(B30) human insulin, Lys(B29)(N-tetradecanoyl)-des(B30) human insulin (insulin detemir, ); B29-N-palmitoyl-des(B30) human insulin; B29-N-myristoyl human insulin; B29-N-palmitoyl human insulin; B28-N-myristoylLysB28ProB29 human insulin; B28-N-palmitoyl-LysB28ProB29 human insulin; B30-N-myristoyl-ThrB29LysB30 human insulin; B30-N-palmitoyl-ThrB29LysB30 human insulin; B29-N-(N-palmitoyl-γ-glutamyl)-des(B30) human insulin, B29-N-ω-carboxypentadecanoyl-γ-L-glutamyl-des(B30) human insulin (insulindegludec, ); B29-N-(N-lithocholyl-γ-glutamyl)-des(B30) human insulin; B29-N-(ω-carboxyheptadecanoyl)-des(B30) human insulin and B29-N-(ω-carboxyheptadecanoyl) human insulin.
[0142] Examples of GLP-1, GLP-1 analogs and GLP-1 receptor agonists are e.g. lixisenatide Exenatide (exendin-4, Liraglutide (a 39-amino acid peptide produced by the salivary glands of the Gila monster) Semaglutide, Taspoglutide, Albiglutide Dulaglutide rExendin-4, CJC-1134-PC, PB-1023, TTP-054, Langlenatide / HM-11260C, CM-3, GLP-1 Eligen, ORMD-0901, NN-9924, NN-9926, NN-9927, Nodexen, Viador-GLP-1, CVX-096, ZYOG-1, ZYD-1, GSK-2374697, DA-3091, MAR-701, MAR709, ZP-2929, ZP-3022, TT-401, BHM-034, MOD-6030, CAM-2036, DA-15864, ARI-2651, ARI-2255, Exenatide-XTEN, and Glucagon-Xten.
[0143] Examples of oligonucleotides are e.g. Mipomersen sodium It is a cholesterol-reducing antisense therapeutic used to treat familial hypercholesterolemia.
[0144] Examples of DPP4 inhibitors are Vildagliptin, Sitagliptin, Denagliptin, Saxagliptin, Berberine.
[0145] Examples of hormones include pituitary hormones or hypothalamic hormones or regulatory activity peptides and their antagonists, such as gonadotropins (follicle-stimulating hormone, luteinizing hormone, chorionic gonadotropin, tocopherol), somatropine (growth hormone), desmopressin, terlipressin, gonadorelin, triptorelin, leuprorelin, buserelin, nafarelin and goserelin.
[0146] Examples of polysaccharides include glucosaminoglycanes, hyaluronic acid, heparin, low molecular weight heparin or ultra low molecular weight heparin or derivatives thereof, or sulfated polysaccharides (e.g., polysulfated forms of the above polysaccharides), and / or pharmaceutically acceptable salts thereof. An example of a pharmaceutically acceptable salt of polysulfated low molecular weight heparin is enoxaparin sodium. An example of a hyaluronic acid derivative is Hylan GF 20 It is a sodium hyaluronate.
[0147] As used herein, the term "antibody" refers to an immunoglobulin molecule or an antigen binding portion thereof. Examples of antigen binding portions of immunoglobulin molecules include F (ab) and F (ab') 2 fragments, which retain the ability to bind antigens. The antibody can be a polyclonal antibody, a monoclonal antibody, a recombinant antibody, a chimeric antibody, a deimmunized or humanized antibody, a fully human antibody, a non-human (e.g., mouse) antibody, or a single-chain antibody. In some embodiments, the antibody has effector functions and can fix complement. In some embodiments, the antibody has reduced or no ability to bind to Fc receptors. For example, the antibody can be an isotype or subtype, an antibody fragment or a mutant, which does not support binding to Fc receptors, for example, it has a mutagenic or missing Fc receptor binding region. The term antibody also includes antigen binding molecules based on tetravalent bispecific tandem immunoglobulins (TBTI) and / or dual variable region antibody-like binding proteins with cross-binding region orientation (CODV).
[0148] The term "fragment" or "antibody fragment" refers to a polypeptide (e.g., antibody heavy and / or light chain polypeptide) derived from an antibody polypeptide molecule, which does not include a full-length antibody polypeptide, but still includes at least a portion of a full-length antibody polypeptide capable of binding an antigen. Antibody fragments can include cleavage portions of full-length antibody polypeptides, although the term is not limited to such cleavage fragments. Antibody fragments that can be used in the present invention include, for example, Fab fragments, F(ab')2 fragments, scFv (single-chain Fv) fragments, linear antibodies, monospecific or multispecific antibody fragments (such as bispecific, trispecific, tetraspecific and multispecific antibodies (e.g., diabodies, triabodies, tetrabodies)), monovalent or multivalent antibody fragments (such as bivalent, trivalent, tetravalent and multivalent antibodies), mini antibodies, chelated recombinant antibodies, triabodies or diabodies, intracellular antibodies, nanobodies, small modular immunopharmaceuticals (SMIPs), binding domain immunoglobulin fusion proteins, camelized antibodies and antibodies comprising VHH. Other examples of antigen-binding antibody fragments are known in the art.
[0149] The term "complementarity determining region" or "CDR" refers to short polypeptide sequences within the variable region of both heavy and light chain polypeptides that are primarily responsible for mediating specific antigen recognition. The term "framework region" refers to amino acid sequences within the variable region of both heavy and light chain polypeptides that are not CDR sequences and are primarily responsible for maintaining the correct positioning of the CDR sequences to allow antigen binding. Although the framework region itself is typically not directly involved in antigen binding, as known in the art, certain residues within the framework region of certain antibodies may be directly involved in antigen binding or may affect the ability of one or more amino acids in the CDR to interact with the antigen.
[0150] Examples of antibodies are anti-PCSK-9 mAb (eg, Alirocumab), anti-IL-6 mAb (eg, Sarilumab), and anti-IL-4 mAb (eg, Dupilumab).
[0151] Pharmaceutically acceptable salts of any API described herein are also contemplated for use as drugs or medicaments in drug delivery devices. Pharmaceutically acceptable salts are, for example, acid addition salts and basic salts.
[0152] Those skilled in the art will appreciate that various components of the API, formulations, devices, methods, systems, and embodiments described herein may be modified (added and / or removed) without departing from the overall scope and spirit of the invention, and that the invention encompasses such modifications and any and all equivalents thereof.
[0153] Reference numerals list
[0154] 101 needle
[0155] 103 Needle shield
[0156] 105 Fork tines
[0157] 107 base part
[0158] 109 Attachment
[0159] 111 Arm
[0160] 113 Clip nail
[0161] 115 Assembly tools
[0162] 117 Lever Arm
[0163] 119 Needle Cover
[0164] 121 Hat
[0165] 123 Closing part
[0166] 125 Cover Block
[0167] 127 Main part
[0168] 129 Cap clamp
[0169] 201 Connecting to the base plate
[0170] 203 Barb
[0171] 205 Arm
[0172] 207 Breakthrough
[0173] 213 Connectors
[0174] 221 Cover wedge
[0175] 223 bevel
[0176] 225 Clamps
[0177] 227 Lid Clamp
[0178] 229 Liang
[0179] 303 Barb
[0180] 305 holes
[0181] 307 Flexible Arm
[0182] 309 Notch
[0183] 313 Ring disk
[0184] 315 Ring
[0185] 317 splice
[0186] 405 Lip
[0187] 407 Gap
[0188] 409 Assembly Tools
[0189] 411 Plunger Tool
[0190] 413 Circlip
[0191] 501 Drug Delivery Device
[0192] 513 Adhesive
Claims
1. An apparatus for removing a needle shield, comprising: - a needle unit comprising a needle (101) arranged along a first axis (Y), - a needle shield (103), said needle shield covering said needle (101), - Main part (127), - a connecting piece (113, 213, 313, 315, 413, 513) for connecting the needle shield (103) to the main part (127) by forced connection or adhesive bonding, so that when the main part (127) is moved away from the needle (101) along the first axis (Y), the needle shield (103) is removed, wherein - the connector (113, 213, 313, 315, 413, 513) comprises at least one movable arm (111, 205) extending along the outer surface of the needle shield (103), wherein - the at least one movable arm (111, 205) is directed towards the needle shield (103) to pass through the attachment portion (109) of the main portion (127); - a cap (121), said cap comprising said main portion (127), wherein said main portion (127) provides an outer surface of said cap (121) and defines an inner space of said cap (121), and - a closing portion (123) covering an opening of the main portion (127) remote from the needle (101), wherein When the closure portion (123) is not connected to the main portion (127), at least one section of the connection member (113, 213, 313, 315, 413, 513) is accessible through the opening, and wherein When the closure part (123) is connected to the main part (127), the connection piece (113, 213, 313, 315, 413, 513) is inaccessible.
2. The device according to claim 1, wherein the attachment part (109) is mechanically connected to the main part (127) or the attachment part (109) is integrated into the main part (127) so that the main part and the attachment part form an integral body structure.
3. The device according to claim 1 or 2, wherein the at least one movable arm (111, 205) comprises at least one tine (105) or barb (203), which extends radially inwardly toward the needle shield (103) so as to establish a forced connection between the at least one tine (105) or barb (203) and the needle shield (103).
4. Apparatus according to claim 1 or 2, comprising a base portion (107, 201) extending perpendicularly to the first axis (Y), and wherein the at least one movable arm (111, 205) is connected to the base portion (107, 201).
5. Device according to claim 3, comprising a base part (107, 201) extending perpendicularly to the first axis (Y), and wherein the at least one movable arm (111, 205) is connected to the base part (107, 201).
6. Device according to claim 4, wherein the at least one movable arm (111, 205) starts from a radial end region of the base part (107, 201) and extends along the first axis (Y), wherein the at least one movable arm (111, 205) has a section extending parallel to the first axis (Y) or radially inwardly toward the first axis in the end region away from the base part (107, 201).
7. Device according to claim 5, wherein the base part (107) is forcibly connected and / or rotationally fastened to the attachment part (109), and the at least one movable arm (111, 205) is forcibly connected to the needle shield (103) via the tine (105) or the barb (203).
8. The apparatus according to claim 4, wherein - the base part (107, 201) is formed as a base plate (201) having a penetration opening (207) arranged at the first axis (Y) for forcibly connecting the base plate (201) to the attachment part (109) of the main part (127), and wherein - said at least one movable arm (205) connected to said base plate (201) extends along said first axis (Y) away from said base plate (201) and towards said needle (101), wherein The at least one movable arm (205) is directed away from the first axis (Y), and wherein The at least one movable arm (205) comprises, at its end, a barb (203) that is bent towards the needle shield (103).
9. Apparatus according to claim 1 or 2, wherein the at least one movable arm (111, 205) is supported against radially outward displacement by support features (119, 221, 225) arranged inside the main portion (127).
10. The device according to claim 1 or 2, wherein the connection (113, 213, 313, 315, 413, 513) comprises two movable arms (111, 205) arranged opposite to each other, wherein the needle shield (103) is arranged between the arms.
11. The device according to claim 1 or 2, wherein the connecting member (113, 213, 313, 315, 413, 513) comprises an annular disk (313) or a ring (315) which surrounds the needle shield (103) so as to establish a positive connection between the annular disk (313) or the ring (315) and the needle shield (103).
12. A method for manufacturing a device according to any one of claims 1 to 11, the method comprising the steps of: - providing a needle unit comprising a needle (101) defining a first axis (Y), - providing a needle shield (103), - Provide the main part (127), - forming a connecting piece (113, 213, 313, 315, 413, 513) for forcibly connecting the needle shield (103) to the main part (127) so that the needle shield (103) can be removed when the main part (127) or the cap (121) having the main part (127) is moved away from the needle (101) along the first axis (Y).
13. An autoinjector (501) comprising a housing and a device according to any one of claims 1 to 11, wherein the main part is connected to the housing and the needle is retained in the housing.
